VelaVigo Cayman Limited - Olean Times Herald

Press Releases

VelaVigo Announces Second Out-Licensing Deal, of a First-in-Class Bi-specific Antibody, Further Validating Its Innovative Discovery Platform and Sustainable BD+VC Business Model

VelaVigo Cayman Limited

April 18, 2025

SHANGHAI and BOSTON , April 17, 2025 /PRNewswire/ -- VelaVigo Bio, the U.S. subsidiary of VelaVigo Cayman Limited (VelaVigo), a biotech company with a...

Press Releases

VelaVigo Announces Second Out-Licensing Deal, of a First-in-Class Bi-specific Antibody, Further Validating Its Innovative Discovery Platform and Sustainable BD+VC Business Model

VelaVigo Cayman Limited

April 17, 2025

SHANGHAI and BOSTON , April 17, 2025 /PRNewswire/ -- VelaVigo Bio, the U.S. subsidiary of VelaVigo Cayman Limited (VelaVigo), a biotech company with a...

Press Releases

VelaVigo Announces Exclusive Option Agreement with Avenzo to License a Potential First-in-Class Nectin4/TROP2 Bispecific Antibody-Drug Conjugate

VelaVigo Cayman Limited

November 18, 2024

SHANGHAI and BOSTON , Nov. 18, 2024 /PRNewswire/ -- VelaVigo Cayman Limited (VelaVigo), a biotech company focusing on discovery and development of mul...

Olean Times Herald

Get in touch with Olean Times Herald

Submit Content

Advertise

Subscribe